期刊文献+

三氧化二砷对VEGF诱导人骨肉瘤SaOS-2细胞TRAF-2和STAT-6表达的影响 被引量:2

Effects of Arsenic Trioxide on the Expression of TRAF-2 and STAT-6 on Human Osteosarcoma SaOS-2 Cell Line Induced by VEGF
下载PDF
导出
摘要 目的通过观察三氧化二砷(As2O3)对血管内皮生长因子(VEGF)诱导人骨肉瘤Sa OS-2细胞肿瘤坏死因子受体相关因子(TRAF-2)和信号转导子与转录激活子(STAT-6)表达的影响,探讨As2O3治疗骨肉瘤的作用机制。方法分别采用CCK8法、实时荧光定量PCR法和流式细胞术测定细胞生长抑制率、TRAF2和STAT-6的表达。结果 2μmol/L的As2O3对Sa OS-2细胞的生长抑制率达57%(0.57±0.03比0)(P<0.01),使VEGF诱导作用显著降低(0.42±0.02)(P<0.05),TRAF-2及STAT-6的表达也显著下降(分别为:149.00±7.21比167.33±8.02;1.29±0.12比2.53±0.67)(P均<0.05)。结论 As2O3可能通过TRAF-2和STAT-6途径对Sa OS-2细胞的生长呈剂量相关的抑制作用。 Objective To investigate the effect of arsenic trioxide(As2O3)on the expression of tumor necrosis factor receptor-associated factor 2(TRAF-2)and signal transducer andactivator of transcription 6(STAT-6)on human osteosarcoma Sa OS-2 cell line induced by vascular endothelial growth factor(VEGF),in an attempt to explore the mechanism of As2O3 treating human osteosarcoma.Methods CCK8 assay,real-time quantitative reverse transcription polymerase chain reaction(QRT-PCR)and flow cytometry methods were used to determine the inhibition rate and expression levels of TRAF-2 and STAT-6 on osteosarcoma Sa OS-2 cell line after treatment with As2O3.Results Treated with As2O3 of 2 μmol/L,the inhibition ratio of SaOS-2 cell line reached 57%(0.57±0.03 vs 0,P〈0.01)and the induction function of VEGF was notably depressed(0.42±0.02,P〈0.05).The expression levels of TRAF-2(149.00±7.21 vs 167.33±8.02)and STAT-6(1.29±0.12 vs 2.53±0.67)significantly decreased(all P〈0.05).Conclusion The inhibition function of As2O3 on osteosarcoma cell proliferation is in a dose-dependent manner,which may be related to TRAF-2 and STAT-6 pathway.
出处 《浙江中西医结合杂志》 2016年第3期215-218,共4页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省自然基金资助项目(No.LY13H080006) 浙江省温岭市科技局基金资助项目(No.2013-1-64)
关键词 骨肉瘤 SAOS-2细胞 AS2O3 TRAF-2 STAT-6 VEGF osteosarcoma Sa OS-2 cell line arsenic trioxide tumor necrosis factor receptor-associated factor 2 signal transducer andactivator of transcription 6 vascular endothelial growth factor
  • 相关文献

参考文献5

二级参考文献55

  • 1郭卫,杨荣利,汤小东,唐顺,李大森,杨毅.成骨肉瘤新辅助化学药物治疗的疗效分析[J].中华医学杂志,2004,84(14):1186-1190. 被引量:23
  • 2方成,陈振光,喻爱喜,祝少博.三氧化二砷诱导骨肉瘤细胞凋亡的实验研究[J].中华骨科杂志,2003,23(6):345-348. 被引量:17
  • 3刘琳,赵伟,秦叔逵,李苏宜,邱少敏,王南瑶,陈惠英.三氧化二砷抗裸鼠人结肠癌移植瘤作用及其机制的研究[J].中国肿瘤临床,2005,32(18):1067-1070. 被引量:10
  • 4汤小东,郭卫,李大森.三氧化二砷诱导尤文肉瘤细胞凋亡及对EWS-FLi1融合蛋白的影响[J].中国肿瘤临床,2005,32(22):1280-1283. 被引量:1
  • 5Wittig JC, Bickels J, Priebat D, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician, 2002, 65 : 1123-1132.
  • 6Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br, 2002, 84: 88-92.
  • 7Meyers PA, Gorlick R, Heller G, et al. Intensification of Preoperative Chemotherapy for Osteogenic Sarcoma: Results of the Memorial Sloan-Kettering (T12) Protocol. J Clin Oncol, 1998, 16 :2452-2458.
  • 8Kushner BH, Meyem PA. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol, 2001, 19: 870-880.
  • 9Guo W, Healey JH, Meyers PA, et al. Mechanisms of Methotrexate Resistance in Osteosarcoma. Clin Cancer Res, 1999, 5:621-627.
  • 10Guo W, Zeng C, Dong F, et al. Paclitaxel-induced apoptosis in osteosarcoma cell line U-2 OS. Chin Med J ( Engl ), 2002, 115 :1796-1801.

共引文献49

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部